During the past decade, Comprehensive Cancer Center Ulm at Universitaetsklinikum Ulm conducted 1 clinical trials. In the 10-year time frame, 1 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Comprehensive Cancer Center Ulm at Universitaetsklinikum Ulm" #1 sponsor was "German CLL Study Group" with 8 trials, followed by "German High-Grade Non-Hodgkin's Lymphoma Study Group" with 5 trials sponsored, "Gesellschaft fur Padiatrische Onkologie und Hamatologie - Germany" with 3 trials sponsored, "European Inter-group Cooperation on Childhood and Adolescent Non Hodgkin Lymphoma" with 1 trials sponsored and "Hoffmann-La Roche" with 1 trials sponsored. Other sponsors include 0 different institutions and companies that sponsored additional 10 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Comprehensive Cancer Center Ulm at Universitaetsklinikum Ulm" #1 collaborator was "Deutsche Krebshilfe e.V., Bonn (Germany)" with 1 trials as a collaborator, "German CLL Study Group" with 1 trials as a collaborator and "University of Cologne" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 3 trials.

According to Clinical.Site data, the most researched conditions in "Comprehensive Cancer Center Ulm at Universitaetsklinikum Ulm" are "Lymphoma" (8 trials), "Chronic Lymphocytic Leukemia" (7 trials), "Leukemia" (3 trials), "Neuroblastoma" (2 trials) and "Acute Lymphoblastic Leukemia, Pediatric" (1 trials). Many other conditions were trialed in "Comprehensive Cancer Center Ulm at Universitaetsklinikum Ulm" in a lesser frequency.

Most popular intervention types in "Comprehensive Cancer Center Ulm at Universitaetsklinikum Ulm" are "Drug" (21 trials), "Biological" (17 trials), "Radiation" (13 trials), "Procedure" (8 trials) and "Other" (3 trials). Other intervention types were less common.

The name of intervention was led by "cyclophosphamide" (12 trials), "radiation therapy" (11 trials), "doxorubicin hydrochloride" (8 trials), "filgrastim" (8 trials) and "vincristine sulfate" (8 trials). Other intervention names were less common.

The vast majority of trials in "Comprehensive Cancer Center Ulm at Universitaetsklinikum Ulm" are 22 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "Comprehensive Cancer Center Ulm at Universitaetsklinikum Ulm". undefined are not yet recruiting, 1 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 17 completed trials in Comprehensive Cancer Center Ulm at Universitaetsklinikum Ulm, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Comprehensive Cancer Center Ulm at Universitaetsklinikum Ulm, 2 "Phase 1" clinical trials were conducted, 8 "Phase 2" clinical trials and 12 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 3 trials that are defined as “Not Applicable".